Cystinosis Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Operating in the Market – Digital Journal

DelveInsight’s Cystinosis Market Insights, Epidemiology, and Market Forecast-2032 report provides an in-depth understanding of cystinosis, historical and forecast epidemiology, and cystinosis market trends in United States, EU5 (Germany, Spain, Italy, France). , and United Kingdom) and Japan.

DelveInsights “Cystinosis Market Insights, Epidemiology and Market Forecast – 2032” The report provides an in-depth understanding of cystinosis, historical and forecast epidemiology, and cystinosis market trends in United States, EU5 (Germany, Spain, Italy, France and UK) and Japan.

The Cystinosis Market report includes current treatment practices, new drugs, the Cystinosis market share of each therapy, and the current and forecast Cystinosis market size from 2019 to 2032, segmented by seven major markets. The report also covers current Cystinosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cystinosis market.

Some of the key facts of the Cystinosis Market report:

• Among the 7MM, the United States has the most diagnosed prevalence of cystinosis with approximately 665 cases in 2021. In the EU-5, the UK has the highest number of cases, namely 224, followed by Germany with 182 cases. Italy has the fewest cases with 43 in 2021.

• In 2021, there were approximately 609 cases of infantile nephropathic cystinosis, 33 cases of juvenile nephropathic cystinosis, and 23 adult cases (ocular or non-nephropathic cystinosis) in the United States. These cases are expected to increase during the forecast period (2022-2032).

• There were approximately 23 diagnosed prevalent cases of cystinosis in Japan in 2021. These cases are expected to decrease over the study period. Of the total diagnosed cases, 21 cases are infantile nephropathic cystinosis, 1 case is juvenile nephropathic cystinosis, and 1 case is adult onset in 2021

Key Benefits of Cystinosis Market Report:

• The report provides a descriptive overview of cystinosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
• A comprehensive insight into cystinosis epidemiology and treatment was given in the 7MM
• In addition, a comprehensive report on current and emerging therapies for cystinosis is provided, along with assessments of emerging therapies that will impact the current treatment landscape
• A Detailed Review of the Cystinosis Market; historical and projected data are included in the report covering drug use in the 7MM
• The report provides an advantage in developing business strategies by understanding trends that are shaping and driving the global Cystinosis market

Do You Have Questions? Click here to learn more about the Cystinosis Market Landscape

Cystinosis Market Overview

Cystinosis is a disease caused by an abnormal buildup of a specific amino acid called cystine. It is a rare but serious disease with lifelong implications and can affect many parts of the body. There are three types of cystinosis, depending on when the first symptoms appear (known as onset): infantile (early onset) cystinosis, late childhood or juvenile (late onset) cystinosis, and adult cystinosis. Cystinosis is a recessive genetic disorder and patients must inherit an abnormal copy of the cystinosis gene from each parent to develop the disease. In people with cystinosis, a buildup of cystine can lead to the formation of crystals. Cystinosis is caused by biallelic mutations in the CTNS gene (17p13.2) encoding cystinosis, a lysosomal cystine proton cotransporter. Consequently, cystine accumulates in the lysosomes of affected cells and forms crystals at low lysosomal pH.

In general, early-onset cystinosis is the most severe form. Symptoms, complications, and timing of cystinosis can vary depending on the type of condition. Cystinosis is diagnosed using a variety of methods, including a physical exam to look for signs of the disease.

Epidemiological insights into the cystinosis market

• In the assessment conducted by DelveInsight, the estimated total number of diagnosed prevalent cases of cystinosis in the 7 million in 2021 was approximately 1,347. Of these, approximately 658 cases of cystinosis have been estimated in the EU5.
• The age of onset, symptoms, and severity of cystinosis can vary widely from person to person. Based on the specific types, the most common types of cystinosis are infantile NC, juvenile NC, and adult-onset. According to DelveInsight, approximately 603 cases of infantile NC, 33 cases of juvenile NC and 23 cases of adult NC were estimated in the EU5 in 2021.
• The total number of predominant cases of cystinosis in the United States was approximately 1,330 in 2021. These widespread cases are expected to increase during the study period.
• The total number of diagnosed prevalent cases of cystinosis in the EU5 was about 659 in 2021. In contrast, in Japan, the diagnosed prevalent cases were estimated at about 23 cases.

Epidemiological segmentation of the cystinosis market

• Common cases of cystinosis
• Cystinosis type specific cases
• Gender specific cystinosis cases
• Age-specific cases of cystinosis

Cystinosis Market Market Outlook

The report’s Cystinosis Market Outlook helps in building a detailed understanding of the historical, current, and forecast Cystinosis Market trends by analyzing the impact of current Cystinosis therapies on the market, unmet needs, drivers, and barriers, and demands for better technology. This segment provides a detailed overview of the Cystinosis market trend of each marketed drug and late-stage pipeline therapy by analyzing their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate and growing be evaluated according to the needs of the market. growing patient pool, patient segment covered, expected launch year, competition from other therapies, brand equity, its impact on the market and key opinion leaders assessment. The calculated Cystinosis market data is presented with relevant tables and graphs to present a clear view of the market at first glance. According to DelveInsight, the cystinosis market in 7MM is expected to experience a major change during the study period 2019-2032.

Learn more by requesting a sample from Cystinosis Market Landscape

Cystinosis Key Companies and Therapies

CuraSen Therapeutics-CST-103

Table of Contents

• Important Findings
• Report introduction
• Summary of Cystinosis
• Disease background and overview
• Epidemiology and patient population
• New therapies for cystinosis
• Cystinosis Market Outlook
• Market access and reimbursement of therapies
• Appendix
• Cystinosis Report methodology
• DelveInsight features
• Disclaimer

About DelveInsight

Click here to learn more about the cystinosis market

media contact
Name of the company: Delve Insight Business Research LLP
Interlocutor: Aja Kaul
E-mail: Send e-mail
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
Federal State: Nevada
Country: United States
Website: https://www.delveinsight.com/